4.6 Review

Dementia with Lewy bodies: an update and outlook

期刊

MOLECULAR NEURODEGENERATION
卷 14, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s13024-019-0306-8

关键词

Dementia with Lewy bodies; Alpha-synuclein; Dementia; Alzheimer's disease; Biomarkers

资金

  1. DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB)
  2. UK Medical Research Council [G0400074]
  3. Brains for Dementia research
  4. NIHR Newcastle Biomedical Research Centre
  5. Newcastle University
  6. NIHR Newcastle Biomedical Research Centre in Ageing and Long-Term Conditions
  7. UK Medical Research Council
  8. National Institutes of Health
  9. Lewy Body Society
  10. Alzheimer's Society
  11. MRC [G0900652, G0502157, G0400074, G1100540] Funding Source: UKRI

向作者/读者索取更多资源

Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressive cognitive decline that interferes with normal life and daily activities. Neuropathologically, DLB is characterised by the accumulation of aggregated alpha-synuclein protein in Lewy bodies and Lewy neurites, similar to Parkinson's disease (PD). Extrapyramidal motor features characteristic of PD, are common in DLB patients, but are not essential for the clinical diagnosis of DLB. Since many PD patients develop dementia as disease progresses, there has been controversy about the separation of DLB from PD dementia (PDD) and consensus reports have put forward guidelines to assist clinicians in the identification and management of both syndromes. Here, we present basic concepts and definitions, based on our current understanding, that should guide the community to address open questions that will, hopefully, lead us towards improved diagnosis and novel therapeutic strategies for DLB and other synucleinopathies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据